Kiersten Stead

Kiersten Stead is a highly experienced professional in the biotechnology and life sciences sectors, currently serving as a board member for multiple companies including Nilo Therapeutics, Radionetics Oncology, Latus Bio, Totus Medicines, Mycoworks, Stemson Therapeutics, Elo Life Systems, and Creyon Bio. In addition, Kiersten holds the position of Managing Partner at DCVC Bio since May 2018 and has been part of the Scientific Advisory Board at Keystone Symposia on Molecular & Cellular Biology since January 2014. Kiersten's academic background includes an MBA with a finance specialization and a Ph.D. in Molecular Biology and Genetics from the University of Alberta, as well as a B.Sc. in Cellular, Molecular and Microbial Biology from the University of Calgary.